Diffusion properties of transurethral intraprostatic injection

BJU International

Volumn 94, Issue 9, 2004, Pages 1384-1388

  Plante, Mark K ^a   Gross, Andrew L ^a   Folsom, Jeffrey B ^a   Zvara, Peter ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Benign prostatic hyperplasia; Diffusion; Ethanol; Transurethral intraprostatic injection

Indexed keywords

DIATRIZOATE; GENTAMICIN; MEGLUMINE DIATRIZOATE; METHYLENE BLUE;

ANIMAL TISSUE; ARTICLE; BLADDER IRRITATION; DIFFUSION; DOG; FLUOROSCOPY; INJECTION SITE; NEEDLE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; STAINING; TRANSURETHRAL NEEDLE ABLATION; URETHRA;

ANIMALS; CONTRAST MEDIA; CYSTOSCOPY; DIATRIZOATE MEGLUMINE; DIFFUSION; DOGS; INJECTIONS; MALE; PROSTATE;

EID: 11144247080     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2004.05177.x     Document Type: Article

References (16)

1. AUA. Guideline on the management of benign prostatic hyperplasia 2003. Chapter 1: Diagnosis and treatment recommendations. J Urol 2003; 170: 530-47
2. Walsh PC, Retik AB, Vaughan ED et al. eds, Campbell's Urology. Eighth edn. Philadelphia: WB Saunders, 2002
3. Buchholz N, Andrews H, Plante MK. Transurethral ethanol ablation of prostate. J Endourol 2004; 18: 519-24
4. Grise P, Plante MK, Palmer J et al. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation. Eur J Urol 2004; 46: 496-501
5. Gutierrez-Aceves J, Gilling P, Schettini M, Grise P, Martinez-Sagarra J, Hernandez C. Transurethral ethanol ablation of the prostate (TEAP), initial long term report of two prospective multicentre studies. J Urol 2003; 169: 466, A1747
6. Plante MK, Palmer J, Martinez-Sagarra J, Guttierrez J, Gilling P. Complications associated with transurethral ethanol ablation of the prostate for the treatment of benign prostatic hyperplasia: a worldwide experience. Abstract Presented at 2003 AUA Meeting, Chicago, Illinois, 2003
7. Plante MK, Gross AL, Kliment J Jr, Kida M, Zvara P. Intraprostatic ethanol chemoablation via transurethral and transperineal injection. BJU Int 2003; 91: 94-8
8. Zvara P, Karpman E, Stoppacher R, Esenler AC, Plante MK. Ablation of canine prostate, using transurethral intraprostatic absolute ethanol injection. Urology 1999; 54: 411-5
9. Adams J, Zvara P, Li S et al. Hypertonic saline ablation for benign prostatic hyperplasia: an alternative to ethanol. In Loughlin KR ed. The 69th Annual Meeting of the New England Section of the American Urological Association. September 24; Le Chateau Frontenac, Quebec City, Quebec, Canada, 2000: 174
10. Plante MK, Folsom JB, Zvara P. Prostatic tissue ablation by injection: a literature review. J Urol 2004; 172: 20-6
11. Plante MK, Bunnell ML, Trotter SJ, Jackson TL, Esenler AC, Zvara P. Transurethral prostatic tissue ablation via a single needle delivery system, initial experience with radio-frequency energy and ethanol. Prostate Cancer Prostatic Dis 2002; 5: 183-8
12. Goya N, Ishikawa N, Ito F et al. Ethanol injection therapy of the prostate for benign prostatic hyperplasia: preliminary report on application of a new technique. J Urol 1999; 162: 383-6
13. Kabra SG, Bhargava M, Jhanwar J, Sharma SK, Pande SK, Chaturvedi RP. Experimental evaluation of injection therapy of enlarged prostate: Part II - fate of the fluid injected. Indian J Exp Biol 1977; 15: 768-71
14. Schlotthauer CF, Bollman JL. The prostate gland of the dog. Cornell Vet 1936; 26: 342-9
15. Bruengger A, Bartsch G, Hollinger BE, Holly B, Rohr HP. Smooth muscle cell of the canine prostate in spontaneous benign hyperplasia, steroid induced hyperplasia and estrogen or tamoxifen treated dogs. J Urol 1983; 130: 1208-10
16. Coffey DS, Walsh PC. Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 1990; 17: 461-75